GR1011108B - Συνθεση για την ενισχυση του ανοσοποιητικου συστηματος - Google Patents

Συνθεση για την ενισχυση του ανοσοποιητικου συστηματος

Info

Publication number
GR1011108B
GR1011108B GR20240100846A GR20240100846A GR1011108B GR 1011108 B GR1011108 B GR 1011108B GR 20240100846 A GR20240100846 A GR 20240100846A GR 20240100846 A GR20240100846 A GR 20240100846A GR 1011108 B GR1011108 B GR 1011108B
Authority
GR
Greece
Prior art keywords
immune system
extract
composition
strengthen
contain
Prior art date
Application number
GR20240100846A
Other languages
English (en)
Inventor
Ιουλια Τσετη
Original Assignee
Ιουλια Τσετη
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ιουλια Τσετη filed Critical Ιουλια Τσετη
Priority to GR20240100846A priority Critical patent/GR1011108B/el
Publication of GR1011108B publication Critical patent/GR1011108B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε συνθέσεις μορφοποιημένες για από του στόματος χορήγηση, κατάλληλες για την ενίσχυση του ανοσοποιητικού συστήματος, οι οποίες συνθέσεις περιέχουν α) μία ή περισσότερες βιταμίνες, β) ένα ή περισσότερα εκχυλίσματα που συμβάλλουν στην ενίσχυση του ανοσοποιητικού συστήματος, κατά προτίμηση εκχύλισμα πρόπολης ή/και εκχύλισμα εχινάκειας ή/και εκχύλισμα κίστου ή/και εκχύλισμα πρίμουλα, γ) ένα ή περισσότερα μέταλλα και δ) ένα ή περισσότερα μη δραστικά έκδοχα και η οποία σύνθεση δεν περιέχει προβιοτικά.
GR20240100846A 2024-11-27 2024-11-27 Συνθεση για την ενισχυση του ανοσοποιητικου συστηματος GR1011108B (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20240100846A GR1011108B (el) 2024-11-27 2024-11-27 Συνθεση για την ενισχυση του ανοσοποιητικου συστηματος

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20240100846A GR1011108B (el) 2024-11-27 2024-11-27 Συνθεση για την ενισχυση του ανοσοποιητικου συστηματος

Publications (1)

Publication Number Publication Date
GR1011108B true GR1011108B (el) 2026-01-19

Family

ID=98932539

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20240100846A GR1011108B (el) 2024-11-27 2024-11-27 Συνθεση για την ενισχυση του ανοσοποιητικου συστηματος

Country Status (1)

Country Link
GR (1) GR1011108B (el)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1520584A1 (en) * 2003-10-01 2005-04-06 Boehringer Ingelheim International GmbH Composition for the activation of the immune system
JP5770702B2 (ja) * 2006-03-24 2015-08-26 ゲオルギオス パンダリス かぜの予防および治療用組成物
US9827203B2 (en) * 2011-02-14 2017-11-28 The Procter & Gamble Company Coated solid dosage forms
US9943503B1 (en) * 2017-10-19 2018-04-17 Edward Wick Pharmaceutical composition for treating bacterial and viral infections
US9980999B2 (en) * 2011-08-19 2018-05-29 Binorica SE Method for producing dry extracts
GR1010228B (el) * 2020-12-09 2022-05-05 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου βιταμινων, μεταλλων, φυσικων εκχυλισματων, προβιοτικων για την ενισχυση του ανοσοποιητικου συστηματος

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1520584A1 (en) * 2003-10-01 2005-04-06 Boehringer Ingelheim International GmbH Composition for the activation of the immune system
JP5770702B2 (ja) * 2006-03-24 2015-08-26 ゲオルギオス パンダリス かぜの予防および治療用組成物
US9827203B2 (en) * 2011-02-14 2017-11-28 The Procter & Gamble Company Coated solid dosage forms
US9980999B2 (en) * 2011-08-19 2018-05-29 Binorica SE Method for producing dry extracts
US9943503B1 (en) * 2017-10-19 2018-04-17 Edward Wick Pharmaceutical composition for treating bacterial and viral infections
GR1010228B (el) * 2020-12-09 2022-05-05 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου βιταμινων, μεταλλων, φυσικων εκχυλισματων, προβιοτικων για την ενισχυση του ανοσοποιητικου συστηματος

Similar Documents

Publication Publication Date Title
BR112022005883A2 (pt) Composições para tratamento bucal anticárie isentas de fluoreto
NZ754962A (en) Compositions and methods for treating, ameliorating and preventing h. pylori infections
CO2017013287A2 (es) Composiciones que comprenden una cepa bacteriana del género roseburia
PH12020550051A1 (en) Glp-1 compositions and uses thereof
BR0116349A (pt) Compostos probióticos derivados da cepa ke01 de lactobacillus casei
EA201791702A1 (ru) Терапевтические средства на основе гликанов и связанные с ними способы
DE60206137D1 (de) Kräuterpflanzen enthaltende artzneimittel
PH12021552089A1 (en) Stable bacterial extracts as pharmaceuticals
ES2141750T3 (es) Composicion que contiene a la vez una forma soluble y una forma insoluble de un inmunogeno.
MX2022001719A (es) Formulaciones de conjugados de benzazepina y usos de las mismas.
TN2015000442A1 (fr) Composition comprenant une association d'un extrait de sureau et d'une souche de lactobacillus rhamnosus
CL2019002218A1 (es) Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
MX2022003754A (es) Composiciones para el cuidado bucal que comprenden acido beta de lupulo y fluoruro.
CL2018002148A1 (es) Uso de cepas bacterianas pertenecientes a la especie lactobacillus kefiri en pediatría para generar y/o mantener un estado de homeostasis.
EA202192860A1 (ru) Сиалилированные гликопротеины
MY209656A (en) Compositions and methods of enhancing 5-hydroxytryptophan bioavailability
GR1011108B (el) Συνθεση για την ενισχυση του ανοσοποιητικου συστηματος
MX2021009578A (es) Formulaciones de dieta para rumiantes.
CO2023012667A2 (es) Combinaciones farmacéuticas para el tratamiento del cáncer
MX2022013868A (es) Composicion para utilizarse en el fortalecimiento del sistema inmunitario en seres humanos y animales para adquirir paninmunidad.
EP4041222A4 (en) Cannabidiol-enhanced probiotic compositions and uses thereof for treatment of infections
EA202192118A1 (ru) Фармацевтическая композиция, содержащая ацетаминофен и ибупрофен
TR201914406A2 (tr) Sapropteri̇n di̇hi̇droklorür ve en az bi̇r farmasöti̇k eksi̇pi̇yan i̇çeren kati oral farmasöti̇k formülasyonlar
MX2023014943A (es) Mezclas nutraceuticas de extractos herbales y bacterias para el mantenimiento de la salud pulmonar.
Floch Gender in probiotic use

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20260206